Cytek Biosciences (CTKB) Capital Expenditures Growth (3y) (2023 - 2026)
Cytek Biosciences (CTKB) Capital Expenditures Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -0.66% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 9.94% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 10.89% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 11.78% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 12.81% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 12.62% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 19.51% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 9.52% |
| 10 | Cytek Biosciences | 604.58 Mn | 530.73 Mn | 28.34 Mn | 19.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.06% |
| Mar 31, 2026 | 149.85% |
| Dec 31, 2025 | -34.85% |
| Sep 30, 2025 | 39.96% |
| Jun 30, 2025 | -28.12% |
| Mar 31, 2025 | 0.87% |
| Dec 31, 2024 | -60.81% |
| Sep 30, 2024 | -36.75% |
| Jun 30, 2024 | 101.31% |
| Mar 31, 2024 | 3.66% |
| Dec 31, 2023 | -32.24% |
| Sep 30, 2023 | 87.37% |